Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bone Biologics Corp Director's Dealing 2020

Jan 17, 2020

35440_dirs_2020-01-17_dd1ee36e-59ef-46a0-9dab-a77b1e35fd24.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2020-01-02

Reporting Person: Hankey Don (Director, Chairman of the Board, 10% Owner)
Reporting Person: HANKEY CAPITAL, LLC (10% Owner)
Reporting Person: Don Hankey Trust (affiliate of 10% owner/dir)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-02 Common Stock P 195000 $1 Acquired 28563398 Indirect

Footnotes

F1: Consists of shares transferred from H&H Funding LLC ("H&H") to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey is the sole manager of H&H. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital and H&H except to the extent of his pecuniary interest.

F2: Mr. Hankey is the beneficial owner of 28,563,398 shares of the Company consisting of 4,062,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 335,000 shares issuable to Hankey Capital upon conversion of debt, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 79,240 shares held by H&H Funding LLC and 320,393 shares issuable upon exercise of warrants issued to Hankey Capital.